MedPath

The Sidney Kimmel Comprehensive Cancer Center

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.hopkinsmedicine.org/kimmel_cancer_center

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Phase 2
Recruiting
Conditions
Urothelial Carcinoma Bladder
Small Cell Neuroendocrine Carcinoma of Bladder
Bladder Cancer
Interventions
First Posted Date
2022-04-05
Last Posted Date
2024-07-03
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
63
Registration Number
NCT05312671
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University: Sibley Memorial Hospital, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS

Phase 2
Withdrawn
Conditions
Retroperitoneal Sarcoma
Interventions
Radiation: Hypofractionated Proton Beam Therapy
First Posted Date
2022-03-31
Last Posted Date
2022-12-15
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registration Number
NCT05302570
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sibley Memorial Hospital, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Hospital, Baltimore, Maryland, United States

RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

Phase 1
Terminated
Conditions
Systemic Sclerosis
Interventions
Biological: RIC alloBMT w PTCy in refractory SSc
First Posted Date
2022-03-28
Last Posted Date
2025-02-04
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
1
Registration Number
NCT05298358
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University, Baltimore, Maryland, United States

KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC

Phase 1
Recruiting
Conditions
Non-Small Cell Lung Cancer
Interventions
Drug: Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides
First Posted Date
2022-02-24
Last Posted Date
2025-04-09
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
12
Registration Number
NCT05254184
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University, Baltimore, Maryland, United States

Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma

Phase 1
Recruiting
Conditions
Pancreatic Cancer
Interventions
Radiation: High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)
First Posted Date
2021-12-02
Last Posted Date
2024-07-16
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
25
Registration Number
NCT05141513
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Hospital, Baltimore, Maryland, United States

TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers

Phase 1
Withdrawn
Conditions
Recurrent Human Papillomavirus Type 16 Associated Cancer
Interventions
First Posted Date
2021-11-24
Last Posted Date
2022-12-01
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registration Number
NCT05132803
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Women & Infants Center, University of Alabama at Birmingham, Birmingham, Alabama, United States

Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors

Not Applicable
Active, not recruiting
Conditions
Sarcoma
Melanoma
Interventions
Radiation: Pro-GRID
First Posted Date
2021-11-16
Last Posted Date
2024-12-19
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
11
Registration Number
NCT05121545
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sibley Memorial Hospital, Washington, District of Columbia, United States

Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma

Not Applicable
Terminated
Conditions
Renal Cell Carcinoma Metastatic
Interventions
Other: Combined Aerobic and Resistance Exercise Training
First Posted Date
2021-11-02
Last Posted Date
2024-04-04
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
2
Registration Number
NCT05103722
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

Phase 1
Recruiting
Conditions
Glioblastoma Multiforme
Interventions
Radiation: Radiation Therapy
First Posted Date
2021-10-19
Last Posted Date
2025-02-24
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
50
Registration Number
NCT05083754
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Medical Institution, Baltimore, Maryland, United States

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Phase 2
Active, not recruiting
Conditions
Metastatic Castration-resistant Prostate Cancer
Prostate Cancer
Castration-resistant Prostate Cancer
Interventions
First Posted Date
2021-10-18
Last Posted Date
2025-05-11
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
30
Registration Number
NCT05081193
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Hospital, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Allegheny Health Network, Pittsburgh, Pennsylvania, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath